Skip to content

Comparing MTA, Emdogain and Human Biological Membrane As A Pulpotomy Agents in Permanent Teeth with Symptoms of Irreversible Pulpitis

Comparative Evaluation Of MTA, Emdogain and Human Biological Membrane As a Pulpotomy Agents in Permanent Teeth With Irreversible Pulpitis: A Randomized Controlled Study - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062861
Enrollment
42
Registered
2024-02-19
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: GROUP 2:Emdogain Gel by Straumann ,Basel, Switzerland and GROUP 3:Freeze-Dried Human Amniotic Membrane From Tissue Bank, Tata Memorial Hospital, Mumbai: After Performing Full Pulpotomy

Sponsors

Zoya Kidwai
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: I Clinical inclusion criteria: 1. Patients with in range of 18 to 45 years of age. 2. Patients presented with deep carious lesions including the first and second permanent molars. 3. No evidence of any clinical pathology · no mobility and had no tenderness to percussion. II Radiographic inclusion criteria: 1. Pre-operative radiographs with no evidence of external or internal root resorption. 2. Absence of furcal radiolucency. 3. Absence of periapical radiolucency or widened periodontal ligament space 4. No more than one-third root resorption detected.

Exclusion criteria

Exclusion criteria: 1. Patient with systemic diseases like diabetes mellitus, hypertension, hepatitis, human immunodeficiency virus, bone disorders, autoimmune disorders. 2. Patient with Periodontally compromised teeth. 3. Pregnant Females.

Design outcomes

Primary

MeasureTime frame
To Check For Vitality Of the Tooth With No Clinical Signs Of Pain and Sensitivity After Using MTA, Emdogain Gel And Human Amniotic Membrane As A Pulpotomy AgentsTimepoint: At 1 month,3 months and 6 months

Secondary

MeasureTime frame
To Check For Any Radiographical Signs Of Disease Progression like Periapical Lesion Formation Or Periodontal Widening After Using MTA, Emdogain Gel And Human Amniotic Membrane As A Pulpotomy AgentTimepoint: At 1 month,3 months and 6 months

Countries

India

Contacts

Public ContactZoya Kidwai

Faculty Of Dental Sciences, King Georges Medical University, Lucknow

promilarajesh@yahoo.co.in9415542063

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026